Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pancreatic ductal adenocarcinoma (a type of pancreatic cancer) and had it confirmed through a biopsy (tissue sample test)
- People who have a permanent home address
- People who agree to take part in the study
- People whose CT scan results are consistent with this type of pancreatic cancer
- People who have had no chemotherapy before, or less than 2 months of chemotherapy given before surgery, for this cancer
- People who are reasonably active and able to care for themselves, as measured by a standard medical scale (rated 0–2 out of 5, meaning from fully active to capable of limited self-care)
Who may not be able to join:
- People under 18 years of age
- People without a permanent home address or a phone number
- People who are pregnant
- People who are currently incarcerated (inmates or prisoners)
- People who are unable to give their own informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nirav Thosani, MD, The University of Texas Health Science Center, Houston
Phone: 713-500-6658
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants who are able to complete neoadjuvant chemotherapy plus EUS-RFA and later undergo surgical tumor resection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.